Akebia Therapeutics

AKBA • NASDAQ • Stock Fundamentals

Akebia Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Butler, with a market cap of $241.3M.

Market Cap$241.3M

Employees167.0

CEOJohn Butler

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Akebia Therapeutics

Akebia Therapeutics (AKBA) has a market capitalization of $241.3M and trades on NASDAQ.

Akebia Therapeutics has approximately 167 employees.